Cart Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Cocaine- and Amphetamine-Regulated Transcript (CART) peptides are major neurotransmitters involved in energy homeostasis, reward, and neurodegeneration. [1]
| Property | Value | [2]
|----------|-------| [3]
| Category | Neuropeptide Receptor Neurons | [4]
| Location | Hypothalamus, Amygdala, Nucleus Accumbens, VTA | [5]
| Ligands | CART peptides (CART 55-102, CART 61-102) | [6]
| Receptor | Multiple (likely GPCR complex) | [7]
| Signaling | Gi/o-coupled, inhibits cAMP |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000197 | sensory receptor cell |
CART signaling has protective effects in AD:
In PD, CART exhibits multiple protective mechanisms:
IHC: CART peptide localization
ELISA: Tissue and plasma CART levels
Mass spectrometry: Peptide quantification
Hypothalamic Neurons
Amygdala Neurons
Alzheimer's Disease Mechanisms
Parkinson's Disease Mechanisms
The study of Cart Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Dominguez et al. CART and reward (2010). 2010. ↩︎
Xu et al. CART neuroprotection in Alzheimer's disease (2012). 2012. ↩︎
Zhang et al. CART in Parkinson's disease (2018). 2018. ↩︎
Jiang et al. CART and mitochondrial function (2019). 2019. ↩︎
Yen et al. CART in stroke and neuroprotection (2020). 2020. ↩︎
Hubert et al. CART receptor pharmacology (2008). 2008. ↩︎
Dayas et al. CART and stress response (2012). 2012. ↩︎